CHED Executive Director Atty. Julito D. Vitriolo discussed the CHED Journal Accreditation Service (JAS) during C&E's Academic Publishing Forum on January 26, 2011 at C&E Information and Resource Center, Quezon City.
How to conduct abstract screening for systematic review – PubricaPubrica
Abstract screening is a necessary step in conducting a thorough and efficient systematic assessment.
• Before screening begins
• During abstract screening
• After screening ends
Continue Reading: https://bit.ly/2UmT1HQ
For our services: https://pubrica.com/services/research-services/systematic-review/
Why Pubrica:
When you order our services, We promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
Scientific research and publication walk throughRoshni Mehta
Humble effort made in the form of this presentation will assist in the accomplishment of exploratory as well as result-oriented research studies. I shall feel amply rewarded if this slides proves helpful in the development of genuine research studies.
As a scientist, we must write, and, as an experimentalist, writing while you work strengthens your research. Writing a paper can be an integral part of observational science. Our manuscript can even be a blueprint for our experiments.
CHED Executive Director Atty. Julito D. Vitriolo discussed the CHED Journal Accreditation Service (JAS) during C&E's Academic Publishing Forum on January 26, 2011 at C&E Information and Resource Center, Quezon City.
How to conduct abstract screening for systematic review – PubricaPubrica
Abstract screening is a necessary step in conducting a thorough and efficient systematic assessment.
• Before screening begins
• During abstract screening
• After screening ends
Continue Reading: https://bit.ly/2UmT1HQ
For our services: https://pubrica.com/services/research-services/systematic-review/
Why Pubrica:
When you order our services, We promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
Scientific research and publication walk throughRoshni Mehta
Humble effort made in the form of this presentation will assist in the accomplishment of exploratory as well as result-oriented research studies. I shall feel amply rewarded if this slides proves helpful in the development of genuine research studies.
As a scientist, we must write, and, as an experimentalist, writing while you work strengthens your research. Writing a paper can be an integral part of observational science. Our manuscript can even be a blueprint for our experiments.
Centralized Resourcing Model for Clinical Trialsjbarag
The clinical research arena is a fast-paced and dynamic entity where it is a standard expectation that a service provider be able to prioritize, re-prioritize, and successfully deliver amidst ever changing timelines while operating in an efficient manner. Though this may sound challenging, it is achievable through the use a centralized resourcing model, supported by valuable tools, enabling a provider to mobilize the appropriate resources at the appropriate time while maintaining budget and utilization targets. Through involvement in this session, participants will become familiar with the key components to the structure of a centralized resourcing model as well as the tools that are paramount to its success. Participants will also learn of several sample scenarios in which they can realize time and cost efficiencies from such a model in all phases of the study lifecycle.
Funders and publishers have something in common: for better or worse, we have the ability to influence the behavior of researchers. This talk will focus on what both groups can do to improve research now and in the future.
Centralized Resourcing Model for Clinical Trialsjbarag
The clinical research arena is a fast-paced and dynamic entity where it is a standard expectation that a service provider be able to prioritize, re-prioritize, and successfully deliver amidst ever changing timelines while operating in an efficient manner. Though this may sound challenging, it is achievable through the use a centralized resourcing model, supported by valuable tools, enabling a provider to mobilize the appropriate resources at the appropriate time while maintaining budget and utilization targets. Through involvement in this session, participants will become familiar with the key components to the structure of a centralized resourcing model as well as the tools that are paramount to its success. Participants will also learn of several sample scenarios in which they can realize time and cost efficiencies from such a model in all phases of the study lifecycle.
Funders and publishers have something in common: for better or worse, we have the ability to influence the behavior of researchers. This talk will focus on what both groups can do to improve research now and in the future.
Traditional RCT
Quasi-experiments
Cohort studies
Case Control Studies
Pragmatic trials
Non-inferiority trials
Complex interventions
The Trend statement
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pubishing in SCI journals (with Chinese translation)
1. Publishing the evidence in SCI
(Science Citation Index) journals
科研证据的SCI发表之路
Roger Watson PhD FRCN FAAN
Editor-in-Chief, JAN
Editor, Nursing Open
@jadvnursing
2. International editorial board 国际编辑委员会
12 issues per year 12期/年
Impact factor 影响因子: 2.267 (7/118)
16130 cites 引用量 (2017)
5. Clarivate journal selection process
期刊遴选过程
Publishing standards 出版标准
•Peer review 同行评议
•Acknowledgments 声明
•Ethical publishing practices 出版伦理规定
•Publishing format 出版格式
•Timeliness 时效
•International editorial conventions 国际编辑惯例
•Full text English 全文英语
6. Clarivate journal selection process
期刊遴选过程
Editorial content 编辑工作
•‘determine if the content of the journal under
evaluation will enrich the database or if the topic
is already adequately addressed in existing
coverage.
确定待评估的期刊内容是否会丰富数据库,或者该
主题是否已在现有报道中得到充分解决。
7. Clarivate journal selection process
期刊遴选过程
International focus 国际聚焦
•‘international diversity among the journal’s
contributing authors, editors, and editorial advisory
board members…’
期刊的撰稿人,编辑和编辑顾问委员会成员之间的国际
多元化
8. Clarivate journal selection process
期刊遴选过程
Citation analysis 引文分析
•Total citation & impact factor 引文总数和影响因子
•Citation history of contributing author and editorial board
members 撰稿人和编辑委员会成员的引文历史
•The field of the journal is accounted for期刊的受众领域
•Self-citation 自引率
17. Enhancing the QUAlity and
Transparency Of health Research
提高健康研究的质量和透明度
CONSORT http://www.consort-statement.org/
18.
19.
20.
21.
22. Enhancing the QUAlity and
Transparency Of health Research
提高健康研究的质量和透明度
CONSORT http://www.consort-statement.org/
PRISMA http://www.prisma-statement.org/
23.
24.
25. Promoting integrity in research publication
促进研究出版物的完整性
COPE http://publicationethics.org/
26.
27.
28. Authorship 署名权
The list of authors should accurately illustrate who
contributed to the work and how. All those listed as authors
should qualify for authorship according to the following
criteria:
作者列表应准确说明谁对工作做出了贡献以及如何做出贡献。
作为作者列出的所有人都应符合以下标准的作者身份
29. Authorship 署名权
1. Have made substantial contributions to conception and design, or acquisition of data, or
analysis and interpretation of data;
为概念和设计,数据采集,数据分析和解释做出了重大贡献;
2. Been involved in drafting the manuscript or revising it critically for important intellectual
content;
参与起草手稿或批判性地修改重要的知识内容;
3. Given final approval of the version to be published. Each author should have participated
sufficiently in the work to take public responsibility for appropriate portions of the content;
and
准许发布最终的版本。 每位作者都应充分参与工作,对内容的适当部分承担公共责任; 和
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately investigated and resolved.
同意对工作的所有方面负责,以确保适当调查和解决与工作任何部分的准确性或完整性相关的
问题。
30. Authorship
Contributions from anyone who does not meet the criteria
for authorship should be listed, with permission from the
contributor, in an Acknowledgments section (for example,
to recognize contributions from people who provided
technical help, collation of data, writing assistance,
acquisition of funding, or a department chairperson who
provided general support). Prior to submitting the article all
authors should agree on the order in which their names will
be listed in the manuscript.
任何不符合作者身份标准的人的贡献应在“致谢”部分中列出,并征得
撰稿人的许可(例如,承认提供技术帮助,数据整理,写作协助,获得
资金的人员的贡献, 或提供一般支持的部门主席)。 在提交文章之前
,所有作者都应该同意他们的名字将在稿件中列出的顺序。
31.
32.
33. Digital object identifier (doi) 数字对象标识符
The Digital Object Identifier (DOI®) System is for identifying content
objects in the digital environment. DOI® names are assigned to any
entity for use on digital networks.
数字对象标识符(DOI®)系统用于识别数字环境中的内容对象。
DOI®名称分配给任何实体以用于数字网络。
They are used to provide current information, including where they
(or information about them) can be found on the Internet.
Information about a digital object may change over time, including
where to find it, but its DOI name will not change.
它们用于提供当前信息,包括可以在Internet上找到它们(或有关它
们的信息)的位置。 有关数字对象的信息可能会随时间而变化,包
括在哪里找到它,但其DOI名称不会改变。
http://www.doi.org/
34. Dealing with reviewer’s comments
应对审稿人的意见
Apply the ‘golden rules’ 应用'黄金法则' (Williams 2004)
Rule 1. Answer completely 规则1.完全回答
Rule 2. Answer politely 规则2.礼貌地回答
Rule 3. Answer with evidence 规则3.用证据回答